Cancer BiologybioRxivPreprint
BRCA2 reversion mutation-independent resistance to PARP inhibition in prostate cancer through loss of function perturbations in the DNA pre-replication complex
Kyrie Pappas, Matteo Ferrari, Perianne Smith…·Charles L. Sawyers
This study identifies loss of function mutations in the DNA pre-replication complex as a mechanism for PARP inhibitor resistance in BRCA-mutant prostate cancer, independent of reversion mutations.